Insulin-dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia.
Benjamin Ole WolthersPernille Rudebeck MogensenThomas Leth FrandsenJonas AbrahamssonMikael BehrendtzMats HeymanOlli LohiUlrika Norén-NyströmEllen RuudKjeld SchmiegelowPublished in: Pediatric blood & cancer (2018)
Pancreatitis is a frequent toxicity to acute lymphoblastic leukemia (ALL) treatment, significantly associated with asparaginase use, and may be followed by severe complications such as acute hyperglycaemia, need for mechanical ventilation, pseudocysts, and death. Here, we provide novel data on seven patients diagnosed with diabetes after pancreatitis and still requiring insulin treatment after a median follow-up of 4.2 years (range: 1.7-9.2). We describe the clinical course of pancreatitis and illustrate the association between pancreatic pseudocysts, older age, and development of insulin-dependent diabetes. Together, this study documents the persisting burden of pancreatitis in childhood ALL and underlines the need for plasma glucose level monitoring.
Keyphrases
- type diabetes
- acute lymphoblastic leukemia
- glycemic control
- mechanical ventilation
- cardiovascular disease
- end stage renal disease
- blood glucose
- allogeneic hematopoietic stem cell transplantation
- ejection fraction
- chronic kidney disease
- risk factors
- physical activity
- insulin resistance
- acute myeloid leukemia
- middle aged
- peritoneal dialysis
- weight loss
- patient reported